Fundly.ai

Paid

Purpose-built fintech platform for India's pharmaceutical retail and…

BharatHunt found and verified this product; its makers did not submit it. Built it? Claim this listing.

No ratings yet
Visit website

Purpose-built fintech platform for India's pharmaceutical retail and distribution sector. Integrated commerce, payment, and credit solutions. Commerce, payments and credit in one system for the retailers, distributors and brands that move medicine across India. Fundly.ai is based in Maharashtra. It is available on iOS and Android, as well as the web.

#ai#fintech#mobile-app

Product profile

Category
Finance
Verified by BharatHunt on the product's site
Pricing
Paid
Verified by BharatHunt on the product's site
AI
Describes itself as AI-powered
Derived from the listing text
What it does
E-commerce, health and care, payments
Derived from the listing text
Who it's for
Marketers
Derived from the listing text
India connection
Based in Maharashtra (verified from company records)
Verified by BharatHunt on the product's site
Available on
Web, iOS, Android
Verified by BharatHunt on the product's site
Launched on BharatHunt
4 Oct 2026
Listing
Discovered and verified by BharatHunt Daily 5
Verified by BharatHunt on the product's site

Why people are discovering this

  • Picked for BharatHunt Daily 5 on 4 October 2026.

Share this product

Help this maker get discovered.

Similar products

Related work, often from other categories — matched on listing text, not on votes.

Alternatives to Fundly.ai

Compare side by side →

Products whose listings describe the same job. Differences come from each listing's own pricing, links and description.

More in Finance

All Finance →

Company

Fundly.ai

Found and verified by BharatHunt; based in Maharashtra.

Fundly.ai on Funding Intelligence →
  • Venture Debt · $4 Mn8 Sept 2026

    Accel, Multiply, former RBL Bank executive director Rajeev Ahuja

    Source: Entrackr

From published funding reports, matched to this product because the company's name and the product's website agree.

Comments (0)

Log in to leave a comment.

No comments yet.